Dear Sir:
In a recent issue of the Journal, Dragsted et al (1) investigated whether fruit and vegetable intake affects biomarkers of oxidative stress or antioxidant defenses. They conducted a well-designed, 25-d, randomized, partly blinded intervention trial. Some of their conclusions related to an apparent lack of effect on markers of total antioxidant capacity [TAC; namely, the ferric-reducing ability of plasma (FRAP) and Trolox-equivalent antioxidant capacity (TEAC)], most of the enzymatic antioxidant defenses (superoxide dismutase, catalase, glutathione reductase, and glutathione S-transferase), and lipid oxidation (isoprostanes and malondialdehyde) in the fruit and vegetable (fruveg) group compared with the placebo group.
TAC measurement, representing the cumulative action of all electron-donating antioxidants present in body fluids, is increasingly being used to monitor redox status in vivo in intervention, bioavailability, and epidemiologic studies (2, 3) . However, different studies have indicated that there may be a physiologic modulation of the redox status of body fluids (4, 5) , and results from the SU.VI.MAX intervention trial indicate the importance of baseline plasma concentrations on the effectiveness of antioxidant supplementation (6) . Therefore, dietary effects on the redox status of healthy subjects may be small and difficult to discern, especially if nonoptimized assay conditions are used. We suggest that the lack of significant variation in plasma antioxidant defenses observed by Dragsted et al may be a consequence of these factors. First, the dietary change failed to modify the redox status of the healthy subjects during the experimental period (see Table 6 in reference 1) and, second, the plasma TAC data could have been adversely affected by suboptimal measurement conditions.
The data of Dragsted et al clearly show that none of the measured redox markers were affected by the withdrawal of fruit and vegetables from the control diet. A decrease in plasma antioxidant concentrations was observed only with vitamin C and carotenoids, which in humans are modest contributors to plasma TAC (7, 8) . We speculate that this indicates that 25 d was not an adequate time period to impair plasma TAC in healthy subjects. Because of the ability to cope with light dietary stress, plasma antioxidant defenses may need 25 d or specific and stronger dietary stresses, such as a high-fat diet, to be challenged significantly. We believe that the lack of change in plasma TAC concentrations in the placebo and fruveg groups could have been due to a physiologic regulatory mechanism that in the short term buffers against significant variation in plasma TAC in healthy young subjects (26 Ȁ 6 y for the fruveg group and 29 Ȁ 8 y for the placebo group).
The lack of observed changes in plasma FRAP and TEAC could also be the result of a decrease in the sensitivity of the TAC measurements as the result of nonoptimized assay techniques. The wavelength used by Dragsted et al to measure both FRAP and TEAC was 620 nm. The correct reference wavelengths are 595 nm for the FRAP assay and 734 nm for the TEAC assay (9, 10) . Experiments conducted in our laboratories indicate that measurement at 620 nm results in a decrease in sensitivity of Ȃ40% and 66% for TEAC and FRAP, respectively. This is borne out by the uncharacteristically high CVs (16.6% and 8.8%, respectively, for TEAC and FRAP) obtained by Dragsted et al compared with reference studies (9, 10) . The difference in vitamin C concentration between the fruveg and the placebo group at the end of the supplementation period was Ȃ60 mol/L (Figure 2 in reference 1) . The expected relative difference in TAC, based on the stoichiometry of ascorbic acid, should have been Ȃ10% for FRAP (10) . This small, but generally discernable, effect on TAC, may have been masked by the reduced sensitivity of the TAC protocols applied in this study.
In conclusion, this interesting and valuable study by Dragsted et al (1) highlights both a requirement for optimized assay conditions and the need to consider the possibility of dynamic mechanisms of control of the body's redox defenses when designing human intervention studies with dietary antioxidants. Measurements of TAC (the sum of the parts) and of single antioxidants (parts of the sum) are useful biomonitoring tools in supplementation and health-related studies of redox balance. However, an understanding of the physiologic mechanisms of control of the body's redox defenses is an important issue that must be addressed to clarify the role of dietary antioxidants in disease prevention.
None of the authors had any conflict of interest. 
Mauro Serafini

Reply to M Serafini et al
Dear Sir:
We appreciate the comments on our paper (1) made by Serafini et al, who highlight some important problems in the interpretation and power of biomarker-based human intervention studies. Serafini et al's letter contains 2 major points of criticism. The first concerns the possibility that our intervention period of 25 d was insufficient to observe a change in fasting measures of antioxidant capacity without an added dietary oxidant stress, such as increased fat. Relatively few human intervention studies have actually been able to show differences in antioxidant capacity, and as far as we are aware, all of these found only postprandial effects. This is the case for studies of tea and chocolate, which have been shown to result in short-term increases in markers of antioxidant capacity equivalent to the increased plasma concentration of catechins (2-6). The tomato study mentioned by Serafini et al also came to this conclusion (7) . In another study, the intervention of 20 -25% changes in fat or total energy intake for 12 wk was insufficient to elicit observable changes in plasma antioxidant capacity (8) .
Thus, we can speculate that prolonged dietary changes are necessary to affect antioxidant capacity. For example, the lifestyle factors leading to type 2 diabetes also result in chronic decreases in plasma antioxidant capacity, apparently as the result of changes in uric acid metabolism (9, 10) . Whether fruit and vegetables would counteract this effect in the long run remains to be investigated. Therefore, our conclusion that a large intake of fruit and vegetables does not affect fasting plasma measures of antioxidant capacity seems valid and in accordance with the literature.
The second criticism concerns our method for measuring plasma antioxidant capacity. According to Serafini et al, an increase in the measurement error may have resulted in our failure to detect minor changes, such as the 10% change calculated from the drop in ascorbate concentrations. Our automated assay of the ferric-reducing ability of plasma (FRAP) and Trolox-equivalent antioxidant capacity (TEAC) was optimized within the boundaries of our equipment, eg, with the absorbance filters available. This decreased sensitivity offset the absolute values of TEAC and increased intra-assay variability compared with the same assays on other equipment. We agree that the intra-day CV of our standard plasma sample was high and understand the concerns of Serafini et al. We have reinvestigated the cause of this and found that other samples and our calibrators had much lower variability, indicating some unidentified problem with our standard plasma. In these other samples, our intra-assay variation was still higher (6.7% for TEAC and 3.9% for FRAP) than the reference values cited in the literature (11, 12) . However, this is unlikely to have caused a type I error in our study because the interindividual variability in FRAP and TEAC was still much higher than the assay variability. The measurement error therefore has relatively little influence on the actual power to detect differences. We observed an overall interindividual CV at baseline of 11.2% for TEAC (x Ȁ SD: 885 Ȁ 99 mol/L) and 22.5% for FRAP (x Ȁ SD: 693 Ȁ 156 mol/L) in the fasting samples (n ҃ 43). In the postprandial samples, the variation was 17.0% and 26.7% (n ҃ 28), respectively. In papers by others, including those cited by Serafini et al, the interindividual CVs for plasma antioxidant activities are variable but similar to ours, eg, 20.6% for FRAP [n ҃ 141 (11)], 21.7% for total radical-trapping antioxidant potential [n ҃ 11 (7)], 9.6% for TEAC [n ҃ 312 (12)], and 18.3% for oxygen radical absorbance capacity [n ҃ 60 (13)].
In our study (1), we tried to increase power by looking at the time course during the intervention with a repeated-samples analysis of covariance (ANCOVA) that used each volunteer's value at baseline as a covariate. In this analysis, the analytic error becomes more important for the power because the interindividual differences are balanced out. However, it still depends on the intraindividual (interday) variation, which in our study was 9.3% for FRAP and 11% for TEAC. This leads to a power of 70% to detect a significant 10% change in TEAC or FRAP [determined by G-power (14) as a post hoc analysis]. In addition to the values at baseline and at the end of intervention (25 d), we measured plasma antioxidant capacity 3, 9, and 16 d after the start of the intervention and 8 and 29 d after the volunteers had resumed their habitual diet. As seen in Figure 1 , there is no indication of deviations from the initial or post-intervention values, as we also confirmed by repeated-samples ANCOVA. In the case of FRAP, the known difference of 25% between men and women (11) was readily observable at all time points, which indicates to us that we would have seen some indication of a 10% change in fasting blood samples. Moreover, the groups with higher initial values were stable throughout.
In conclusion to this point, we agree that our assay sensitivity was probably not optimal and that our absolute values for TEAC may have been offset by the shortcomings of our automated equipment. However, we disagree that this seriously affected our power to detect a real change in measures of antioxidant capacity. The major source of noise in the measurement of plasma antioxidant capacity is the interindividual variation, which was similar in our study to that 532 LETTERS TO THE EDITOR observed by others, including the cited reference studies. Consequently, we still conclude that there was no significant effect of fruit and vegetables on fasting plasma antioxidant capacity within the 25-d study period.
None of the authors had any conflict of interest related to the results and discussion published in this letter. 
LO Dragsted
Body mass index and survival in incident dialysis patients: the answer depends on the question
In a recent issue of the journal, Johansen et al (1) examined an important question-What is the association of body size with survival adjusted for muscle mass in incident dialysis patients? However, there are really 3 questions: 1) What is the independent association between muscle mass and mortality, 2) What is the independent association between BMI and mortality, and 3) How does mortality vary across different levels of BMI and muscle mass combined. Based on the answer to the question posed by Johansen et al, inferences on whether body composition influences the survival of incident dialysis patients with a high BMI could not be drawn.
We reexamined the data from our earlier study (2) , which the authors graciously discussed. Details on study population, inclusion criteria, data collection, and statistical methods were described earlier (2) . In 70 028 incident hemodialysis patients in the United States, from 1 January 1995 to 31 December 1999, the associations of BMI categories described by Johansen et al with survival were examined in a multivariable parameteric proportional hazards survival model adjusted for urinary creatinine, demographics, comorbid conditions, serum albumin, and functional status. The results (Figure 1 ) are similar to those reported by Johansen et al.
To further examine the influence of body composition on survival in high-BMI patients, each of the BMI groups was divided into groups on the basis of muscle mass: low (urinary creatinine ͨ25th percentile, ie, ͨ0.55 g/d), normal, or high (urinary creatinine 0.55 g/d) subgroups. The hazard ratios from the multivariable parameteric proportional hazards survival model, adjusted for all of the above factors except urinary creatinine, are presented in Figure 2 .
At first glance, Figures 1 and 2 appear contradictory, but, in reality, they are not. Adjustment for urinary creatinine in the multivariable model (Figure 1 ) does not mean that the hazard of death is constant across the spectrum of urinary creatinine values in any 534 LETTERS TO THE EDITOR given BMI group (Figure 2) . Whether the association of BMI with survival is confounded by muscle mass is examined in Figure 1 . Whether those with a large body size but low muscle mass have a survival advantage over "healthy" patients with a normal BMI and a normal or high muscle mass is examined in Figure 2 .
In our study we summarized the findings in Figure 2 as "the survival advantage conferred by high BMI in dialysis patients is limited to patients with normal or high muscle mass." We understand the concerns of Johansen et al that this could be construed as independence. We rephrase our conclusions as follows. Patients with a high BMI and low muscle mass have a higher mortality than do "healthy" incident dialysis patients with a normal BMI and normal or high muscle mass. On the other hand, patients with a high BMI and normal or high muscle mass have a lower mortality than do "healthy" incident dialysis patients with a normal BMI and normal or high muscle mass. Thus, compared with "healthy" incident dialysis patients with a normal BMI and normal or high muscle mass, those with a high BMI have a lower mortality only if their muscle mass is normal or high.
In conclusion, the questions addressed in the 2 studies were related but had different emphases. We absolutely agree with Johansen et al that body size is an important determinant of survival in incident dialysis patients. However, we stand by our earlier conclusion that, in incident dialysis patients, body size and body composition influence survival. In incident dialysis patients, adiposity confers a survival advantage over undernutrition, but higher muscle mass is better than higher body fat. We agree that, given the current data, incident dialysis patients should not be encouraged to lose weight but should be encouraged to increase muscle mass rather than fat mass.
None of the authors had a conflict of interest.
